Showing results (671-680 of 710) with videos related to

Sort By:
Pageof 71
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2023
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM)Naveen S Vasudev, Gemma Ainsworth, Sarah Brown, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Digital Pathology Transformation in a Supraregional Germ Cell Tumour NetworkRichard Colling, Andrew Protheroe, Mark Sullivan, et al.
BJU International|February 26, 2026
The PRAGMATIC pathway - PRostate cancer diAGnosis and MAnagement Triage In Clinical careAbhishek Sharma, Teresa Campbell, Sagar Kanabar, et al.
CBE Life Sciences Education|April 29, 2017
Broadening Participation in Biology Education Research: Engaging Community College Students and FacultyJeffrey N Schinske, Virginia L Balke, M Gita Bangera, et al.
Gastroenterology|June 20, 2021
Interferon-Gamma-Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-ColitisSarah C Sasson, Stephanie M Slevin, Vincent T F Cheung, et al.
The Lancet. Oncology|September 13, 2020
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trialNicholas C Turner, Belinda Kingston, Lucy S Kilburn, et al.
Journal of Pathology Informatics|December 19, 2012
Pathology informatics fellowship retreats: The use of interactive scenarios and case studies as pathology informatics teaching toolsRoy E Lee, David S McClintock, Ulysses J Balis, et al.
Journal of Medicinal Chemistry|September 16, 2008
Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)Bertrand Le Bourdonnec, Rolf T Windh, Christopher W Ajello, et al.
Journal of Medicinal Chemistry|August 22, 2009
Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747)Bertrand Le Bourdonnec, Rolf T Windh, Lara K Leister, et al.
Diabetes|August 8, 2013
Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesityStefania Carobbio, Rachel M Hagen, Christopher J Lelliott, et al.
Pageof 71